New study finds interferon-γ release assays more effective than skin tests in predicting tuberculosis

FHS
April 5, 2024
9:57 am

The performance of tuberculin skin test (TST) and interferon-γ release assays (IGRAs) in predicting tuberculosis (TB).

Can muvalaplin achieve safe and tolerable plasma concentrations adequate to reduce steady-state Lp(a) levels without modulating plasminogen activity in humans?

Researchers evaluated the tolerability, safety, pharmacodynamics, and pharmacokinetic properties of muvalaplin.

August 30, 2023

Public voices often ignored in states’ opioid settlement money decisions

The conversation wasn’t sounding good for Kensington residents on June 20. The Philadelphia neighborhood is a critical center of the nation’s opioid crisis, and the

August 27, 2024

‘Like a Russian roulette’: US military firefighters grapple with unknowns of PFAS exposure

A U.S. military firefighter for 32 years, Kurt Rhodes trained and performed his duties with aqueous film forming foam, or AFFF — a highly effective

September 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.